首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   252667篇
  免费   18316篇
  国内免费   1138篇
耳鼻咽喉   2793篇
儿科学   6524篇
妇产科学   4612篇
基础医学   33107篇
口腔科学   4570篇
临床医学   25459篇
内科学   53802篇
皮肤病学   3387篇
神经病学   24395篇
特种医学   8429篇
外国民族医学   11篇
外科学   38637篇
综合类   3471篇
一般理论   319篇
预防医学   21479篇
眼科学   6570篇
药学   17046篇
  6篇
中国医学   364篇
肿瘤学   17140篇
  2023年   1343篇
  2022年   2429篇
  2021年   5456篇
  2020年   3273篇
  2019年   5315篇
  2018年   5967篇
  2017年   4479篇
  2016年   4973篇
  2015年   5847篇
  2014年   8629篇
  2013年   11838篇
  2012年   18081篇
  2011年   18969篇
  2010年   10598篇
  2009年   9460篇
  2008年   16662篇
  2007年   17510篇
  2006年   17347篇
  2005年   17321篇
  2004年   16219篇
  2003年   15064篇
  2002年   14083篇
  2001年   2130篇
  2000年   1618篇
  1999年   2331篇
  1998年   3077篇
  1997年   2567篇
  1996年   2189篇
  1995年   2107篇
  1994年   1763篇
  1993年   1572篇
  1992年   1275篇
  1991年   1154篇
  1990年   1007篇
  1989年   988篇
  1988年   984篇
  1987年   966篇
  1986年   963篇
  1985年   986篇
  1984年   1232篇
  1983年   1138篇
  1982年   1371篇
  1981年   1322篇
  1980年   1152篇
  1979年   714篇
  1978年   757篇
  1977年   641篇
  1976年   591篇
  1975年   472篇
  1974年   490篇
排序方式: 共有10000条查询结果,搜索用时 11 毫秒
1.
2.
3.
4.
5.
6.
7.
8.
9.
Academic output is just one aspect of a successful career as a plastic surgeon. However, for those with a strong interest in academia, the academic output of a department will likely be a key factor when deciding how to rank jobs. The aim of this study was to quantify and rank the academic output of plastic surgery units across the UK and Ireland. The Institute for Scientific Information (ISI) Web of Science Bibliometric analysis tool was used to collate cumulative (1950–2016), 10 year (2006–2016) and 3 years (2013–2015) research output data for plastic surgery units in the UK and Ireland. Sixty-six plastic surgery units were identified. Departments were ranked for each time period according to the number of papers produced, number of citations (Nc) and h-index (a measure of the impact of scientific output). The top 3 departments for number of papers in the last 10 years were The Royal Free Hospital, London (226) Broomfield Hospital, Chelmsford (218), and Morriston Hospital and Swansea (188). The top 3 for h-number were The Royal Free Hospital (21) Wythenshawe Hospital, Manchester (18) and Morriston Hospital (17). Academic output varies across plastic surgery units in the UK and Ireland. A number of departments have consistently maintained high academic outputs across the years and will be of interest to surgeons hoping to pursue a career in academia.  相似文献   
10.

Objective

Comparative survival between neoadjuvant chemotherapy and adjuvant chemotherapy for patients with cT2-4N0-1M0 non–small cell lung cancer has not been extensively studied.

Methods

Patients with cT2-4N0-1M0 non–small cell lung cancer who received platinum-based chemotherapy were retrospectively identified. Exclusion criteria included stage IV disease, induction radiotherapy, and targeted therapy. The primary end point was disease-free survival. Secondary end points were overall survival, chemotherapy tolerance, and ability of Response Evaluation Criteria In Solid Tumors response to predict survival. Survival was estimated using the Kaplan–Meier method, compared using the log-rank test and Cox proportional hazards models, and stratified using matched pairs after propensity score matching.

Results

In total, 330 patients met the inclusion criteria (n = 92/group after propensity-score matching; median follow-up, 42 months). Five-year disease-free survival was 49% (95% confidence interval, 39-61) for neoadjuvant chemotherapy versus 48% (95% confidence interval, 38-61) for adjuvant chemotherapy (P = .70). On multivariable analysis, disease-free survival was not associated with neoadjuvant chemotherapy or adjuvant chemotherapy (hazard ratio, 1.1; 95% confidence interval, 0.64-1.90; P = .737), nor was overall survival (hazard ratio, 1.21; 95% confidence interval, 0.63-2.30; P = .572). The neoadjuvant chemotherapy group was more likely to receive full doses and cycles of chemotherapy (P = .014/0.005) and had fewer grade 3 or greater toxicities (P = .001). Response Evaluation Criteria In Solid Tumors response to neoadjuvant chemotherapy was associated with disease-free survival (P = .035); 15% of patients receiving neoadjuvant chemotherapy (14/92) had a major pathologic response.

Conclusions

Timing of chemotherapy, before or after surgery, is not associated with an improvement in overall or disease-free survival among patients with cT2-4N0-1M0 non–small cell lung cancer who undergo complete surgical resection.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号